SCHEMBL2964680

SCHEMBL2964680

CCC1=Cc2cc(Br)ccc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.39
PNMT P11086 4/20 0.37
ADRA2A P08913 2/20 0.37
ADRA2B P18089 2/20 0.37
ADRA2C P18825 2/20 0.37
CMA1 P23946 1/20 0.33
AHR P35869 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B3 P37058 1/20 0.33
METAP1 P53582 1/20 0.33
ALOX5 P09917 1/20 0.32
TDP2 O95551 1/20 0.32
ACHE P22303 1/20 0.31
ASIC3 Q9UHC3 1/20 0.31
HTR2A P28223 3/20 0.31
HTR2C P28335 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2974941 0.86 TRPA1 (0.37) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2972221 0.85 PNMT (0.37) PNMTADRA2AADRA2BADRA2CCMA1
SCHEMBL2964973 0.83 TRPA1 (0.36) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2969428 0.82 TRPA1 (0.35) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2969538 0.80 TRPA1 (0.34) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2970635 0.80 TRPA1 (0.34) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2971444 0.80 TRPA1 (0.34) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2974541 0.80 TRPA1 (0.34) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL2974889 0.80 TRPA1 (0.34) TRPA1PNMTADRA2AADRA2BADRA2C
SCHEMBL1640209 0.80 TRPA1 (0.38) TRPA1PNMTCMA1AHRMETAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 TRPA1 438/4885PNMT 2021/4885ADRA2A 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.